Umthengisi weCelecoxib CAS:169590-42-5
I-Celecoxib okwangoku isetyenziselwa ukuphelisa iimpawu ze-osteoarthritis kunye ne-rheumatoid arthritis kunye nokunciphisa inani le-adenomatous colorectal polyps kwi-familial adenomatous polyposis njenge-adjunct kwinkathalo eqhelekileyo.
I-Celecoxib yenziwa ngokufunxa i-4-methyl-acetophenone kunye ne-ethyltrifluoroacetate nge-sodium methoxide kwaye i-butanedione derivative ephumayo ijikeleziswe nge-4-hydrazinophenylsulfonamide. Yayiyi-NSAID yokuqala ukuthengiswa njenge-COX-2 inhibitor ekhethiweyo.
| Ukwakhiwa | C17H14F3N3O2S |
| Uvavanyo | 99% |
| Inkangeleko | Umgubo omhlophe ukuya komhlophe ongekho mhlophe |
| Inombolo ye-CAS | 169590-42-5 |
| Ukupakisha | 25KG |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Indawo yokugcina izinto | Gcina kwindawo epholileyo neyomileyo |
| Isiqinisekiso | I-ISO. |
Bhala umyalezo wakho apha uze uwuthumele kuthi








